Related Experiment Video
Updated: Aug 3, 2025
11:44
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
7.7K
Circular RNAs-mediated angiogenesis in human cancers
Farhoodeh Ghaedrahmati1, Ava Nasrolahi2, Sajad Najafi3
1Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Summary
Circular RNAs (circRNAs) impact tumor growth by affecting angiogenesis, the process of new blood vessel formation. These non-coding RNAs offer potential for cancer diagnosis and prognosis.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Circular RNAs (circRNAs) are non-coding RNAs with cell-specific expression involved in physiological and pathological processes.
- Angiogenesis, crucial for tumor progression, supplies nutrients and energy to tumors.
- Aberrant circRNA expression influences tumor development by modulating angiogenesis, linking to cancer hallmarks.
Purpose of the Study:
- To review the angiogenic impacts of circRNAs in human cancers.
- To explore anti-angiogenic strategies involving circRNAs for cancer management.
Main Methods:
- Literature review of studies on circRNAs, angiogenesis, and cancer.
- Analysis of research on circRNA functions in tumor progression and metastasis.
- Evaluation of circRNAs as diagnostic and prognostic biomarkers in malignancies.
Main Results:
- CircRNAs play significant roles in regulating angiogenesis, affecting tumor growth and metastasis.
- Dysregulated circRNAs are implicated in various hallmarks of cancer.
- Abnormal circRNA expression patterns can serve as biomarkers for cancer diagnosis and prognosis.
Conclusions:
- CircRNAs are critical regulators of angiogenesis in cancer.
- Targeting circRNAs offers potential for novel anti-angiogenic cancer therapies.
- CircRNAs hold promise as biomarkers for early cancer detection and predicting patient outcomes.
More Related Videos
09:03Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
Published on: November 23, 2014
9.8K
09:03Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay
Published on: June 30, 2023
1.0K
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
01:10Mechanism of Angiogenesis
5.7K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.7K
02:39lncRNA - Long Non-coding RNAs
8.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:15Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
01:22MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K